"The goal of the treatment with NORTHERA is to make the symptoms better. In my opinion, NORTHERA is the first medication that I would prescribe for nOH.”
–Dr. Salima Brillman, movement disorder specialist and paid Lundbeck consultant
If you decide that NORTHERA is clinically appropriate for your patients, write “Dispense as written” on the prescription to help ensure patients receive their medication exactly as prescribed.
"The goal of the treatment with NORTHERA is to make the symptoms better. In my opinion, NORTHERA is the first medication that I would prescribe for nOH.”
–Dr. Salima Brillman, movement disorder specialist and paid Lundbeck consultant
“I prescribe NORTHERA for a patient who has symptoms of nOH like dizziness, lightheadedness, feeling like they might pass out; that happens when they stand up.”
–Dr. David Shprecher, movement disorder specialist and paid Lundbeck consultant
“nOH never goes away, but with NORTHERA…I don’t even think about it anymore, to be honest with you.”
–Gail, a real patient living with Parkinson’s disease and symptomatic nOH
Patient experiences vary and not all patients may benefit from NORTHERA treatment.
References:
1. NORTHERA [package insert]. Deerfield, IL: Lundbeck. 2. Freeman R. N Engl J Med. 2008;358(6):615-624.
Please see Important Safety Information, including Boxed Warning for supine hypertension.
For more information, see the full Prescribing Information.
Indications and Usage
NORTHERA (droxidopa) is indicated for the treatment of orthostatic dizziness, lightheadedness, or the “feeling that you are about to black out” in adult patients with symptomatic neurogenic orthostatic hypotension (nOH) caused by primary autonomic failure (Parkinson’s disease [PD], multiple system atrophy, and pure autonomic failure), dopamine beta-hydroxylase deficiency, and non-diabetic autonomic neuropathy. Effectiveness beyond 2 weeks of treatment has not been established. The continued effectiveness of NORTHERA should be assessed periodically.
Important Safety Information
WARNING: SUPINE HYPERTENSION
Monitor supine blood pressure prior to and during treatment and more frequently when increasing doses. Elevating the head of the bed lessens the risk of supine hypertension, and blood pressure should be measured in this position. If supine hypertension cannot be managed by elevation of the head of the bed, reduce or discontinue NORTHERA.
CONTRAINDICATIONS
WARNINGS AND PRECAUTIONS
ADVERSE REACTIONS
DRUG INTERACTIONS
USE IN SPECIFIC POPULATIONS
For more information, please see the full Prescribing Information, including Boxed Warning for supine hypertension.